FR2790388B1 - Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption - Google Patents

Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption

Info

Publication number
FR2790388B1
FR2790388B1 FR9902680A FR9902680A FR2790388B1 FR 2790388 B1 FR2790388 B1 FR 2790388B1 FR 9902680 A FR9902680 A FR 9902680A FR 9902680 A FR9902680 A FR 9902680A FR 2790388 B1 FR2790388 B1 FR 2790388B1
Authority
FR
France
Prior art keywords
benzamide
pharmaceutical compositions
absorption promoter
promoter
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9902680A
Other languages
English (en)
Other versions
FR2790388A1 (fr
Inventor
Alain Dufour
Frederic Andre
Gareth Lewis
Anne Charlier
Cecile Jaume
Gerard Gillet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9902680A priority Critical patent/FR2790388B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to AU29228/00A priority patent/AU2922800A/en
Priority to PCT/FR2000/000504 priority patent/WO2000051563A1/fr
Priority to CO00014726A priority patent/CO5440229A1/es
Priority to CA002362480A priority patent/CA2362480A1/fr
Priority to JP2000602033A priority patent/JP2002538094A/ja
Priority to ARP000100941A priority patent/AR022819A1/es
Priority to PE2000000186A priority patent/PE20001554A1/es
Priority to UY26050A priority patent/UY26050A1/es
Publication of FR2790388A1 publication Critical patent/FR2790388A1/fr
Application granted granted Critical
Publication of FR2790388B1 publication Critical patent/FR2790388B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
FR9902680A 1999-03-04 1999-03-04 Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption Expired - Fee Related FR2790388B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR9902680A FR2790388B1 (fr) 1999-03-04 1999-03-04 Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
PCT/FR2000/000504 WO2000051563A1 (fr) 1999-03-04 2000-03-01 Compositions pharmaceutiques pour l'administration orale comprenant un benzamide et au moins un promoteur d'absorption
CO00014726A CO5440229A1 (es) 1999-03-04 2000-03-01 Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas asi como por lo menos un promotor de absorcion
CA002362480A CA2362480A1 (fr) 1999-03-04 2000-03-01 Compositions pharmaceutiques pour l'administration orale comprenant un benzamide et au moins un promoteur d'absorption
AU29228/00A AU2922800A (en) 1999-03-04 2000-03-01 Pharmaceutical compositions for oral administration comprising a benzamide and at least an absorption promoter
JP2000602033A JP2002538094A (ja) 1999-03-04 2000-03-01 ベンズアミドおよび少なくとも一種の吸収促進剤を含有する経口投与用の医薬組成物
ARP000100941A AR022819A1 (es) 1999-03-04 2000-03-03 Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas, asi como por lo menos unpromotor de absorcion
PE2000000186A PE20001554A1 (es) 1999-03-04 2000-03-03 Composiciones farmaceuticas para la administracion oral que comprende una benzamida y por lo menos un promotor de absorcion
UY26050A UY26050A1 (es) 1999-03-04 2000-03-03 Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas asi como por lo menos un promotor de absorcion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9902680A FR2790388B1 (fr) 1999-03-04 1999-03-04 Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption

Publications (2)

Publication Number Publication Date
FR2790388A1 FR2790388A1 (fr) 2000-09-08
FR2790388B1 true FR2790388B1 (fr) 2001-04-13

Family

ID=9542809

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9902680A Expired - Fee Related FR2790388B1 (fr) 1999-03-04 1999-03-04 Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption

Country Status (9)

Country Link
JP (1) JP2002538094A (fr)
AR (1) AR022819A1 (fr)
AU (1) AU2922800A (fr)
CA (1) CA2362480A1 (fr)
CO (1) CO5440229A1 (fr)
FR (1) FR2790388B1 (fr)
PE (1) PE20001554A1 (fr)
UY (1) UY26050A1 (fr)
WO (1) WO2000051563A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
CN101507432B (zh) * 2009-04-02 2012-12-19 河北省林业科学研究院 香芹酚微乳剂及其生产工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
EP0303445A1 (fr) * 1987-08-13 1989-02-15 Walton S.A. Pansement pour l'administration transdermique de clébopride
JPH01236980A (ja) * 1988-03-14 1989-09-21 Iseki & Co Ltd 小米選別装置付き貯留タンク
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique

Also Published As

Publication number Publication date
CA2362480A1 (fr) 2000-09-08
PE20001554A1 (es) 2001-03-18
WO2000051563A1 (fr) 2000-09-08
CO5440229A1 (es) 2004-09-30
AU2922800A (en) 2000-09-21
UY26050A1 (es) 2000-09-29
AR022819A1 (es) 2002-09-04
FR2790388A1 (fr) 2000-09-08
JP2002538094A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
MA23441A1 (fr) Formulation nouvelle comprenant un complexe de paroxetine et d'amberlite "irp 88".
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita' analgesica
DE69524592T2 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
DE69324826D1 (de) Gegen Papillomaviren wirksame 2',5'-OLIGOADENYLAT-2',3'-CYCLOPHOSPHATE und 2',5'-OLIGOADENYLATE
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
FI964031A0 (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
BR9509688A (pt) Composto e composição farmacêutica
ITMI962423A0 (it) Composizione farmaceutica orale ad attivita' antipiretica analgesica e infiammatoria
FR2790388B1 (fr) Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
DE69512715D1 (de) Aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
HUP0105359A3 (en) Benzamide derivatives and drugs containing the same
FI964879A0 (fi) Uusia, 1,1-bis(heteroazolyyli)alkaanijohdoksia ja niiden käyttö hermostoa suojelevina aineina
DE59503889D1 (de) Entstaubungsmittel
DE69422496D1 (de) Mittel gegen malaria
ITRM940387A0 (it) "giunto a tampone viscoelastico anidro".
FR2795972B1 (fr) Ensemble comprenant une barre-support et au moins une figurine pour jeu de table et jeu de table pourvu d'au moins un tel ensemble
IT1293525B1 (it) Bis-acridincarbossiammidi aventi attivita' antitumorale
ITMI972373A1 (it) Composizioni farmaceutiche ad attivita'analgesica
BR9505130A (pt) Composto e composiçao farmacêutica
IT1269316B (it) Composizioni farmaceutiche ad attivita' antitossica
ITMI930453A1 (it) Composizione farmaceutica avente attivita' antiasmatica

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse